Hirao, T., Yamaguchi, M., Kikuya, M., Chibana, H., Ito, K., & Aoki, S. (2017). Altered intracellular signaling by imatinib increases the anti‐cancer effects of tyrosine kinase inhibitors in chronic myelogenous leukemia cells. Cancer Sci.

Hirao, Takuya, Masashi Yamaguchi, Megumi Kikuya, Hiroji Chibana, Kousei Ito, και Shigeki Aoki. "Altered Intracellular Signaling By Imatinib Increases the Anti‐cancer Effects of Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia Cells." Cancer Sci 2017.

Hirao, Takuya, et al. "Altered Intracellular Signaling By Imatinib Increases the Anti‐cancer Effects of Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia Cells." Cancer Sci 2017.